272 related articles for article (PubMed ID: 34995318)
1. Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load.
Rye MS; Garrett KL; Holt RA; Platell CF; McCoy MJ
PLoS One; 2022; 17(1):e0262416. PubMed ID: 34995318
[TBL] [Abstract][Full Text] [Related]
2. Association of Fusobacterium nucleatum infection with colorectal cancer in Chinese patients.
Li YY; Ge QX; Cao J; Zhou YJ; Du YL; Shen B; Wan YJ; Nie YQ
World J Gastroenterol; 2016 Mar; 22(11):3227-33. PubMed ID: 27004000
[TBL] [Abstract][Full Text] [Related]
3. Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.
Yamaoka Y; Suehiro Y; Hashimoto S; Hoshida T; Fujimoto M; Watanabe M; Imanaga D; Sakai K; Matsumoto T; Nishioka M; Takami T; Suzuki N; Hazama S; Nagano H; Sakaida I; Yamasaki T
J Gastroenterol; 2018 Apr; 53(4):517-524. PubMed ID: 28823057
[TBL] [Abstract][Full Text] [Related]
4. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
Tunsjø HS; Gundersen G; Rangnes F; Noone JC; Endres A; Bemanian V
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1367-1376. PubMed ID: 31025134
[TBL] [Abstract][Full Text] [Related]
5. Fusobacterium nucleatum is associated with worse prognosis in Lauren's diffuse type gastric cancer patients.
Boehm ET; Thon C; Kupcinskas J; Steponaitiene R; Skieceviciene J; Canbay A; Malfertheiner P; Link A
Sci Rep; 2020 Oct; 10(1):16240. PubMed ID: 33004953
[TBL] [Abstract][Full Text] [Related]
6. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population.
Suehiro Y; Sakai K; Nishioka M; Hashimoto S; Takami T; Higaki S; Shindo Y; Hazama S; Oka M; Nagano H; Sakaida I; Yamasaki T
Ann Clin Biochem; 2017 Jan; 54(1):86-91. PubMed ID: 27126270
[TBL] [Abstract][Full Text] [Related]
7. [The Relationship of Enterotoxigenic Bacteroides fragilis and Fusobacterium nucleatum Intestinal Colonization with Colorectal Cancer: A Case-Control Study Performed with Colon Biopsies].
Öztürk Bakar Y; Demiryas S; Ceylan Kılınçarslan A; Demirci M; Kepil N; Bakar MT; Taner Z; Tokuç E; Ziyad MA; Taşçı İ; Kocazeybek BS; Bahar Tokman H
Mikrobiyol Bul; 2023 Jul; 57(3):353-364. PubMed ID: 37462300
[TBL] [Abstract][Full Text] [Related]
8. Quantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer.
Viljoen KS; Dakshinamurthy A; Goldberg P; Blackburn JM
PLoS One; 2015; 10(3):e0119462. PubMed ID: 25751261
[TBL] [Abstract][Full Text] [Related]
9. High frequency of enterotoxigenic Bacteroides fragilis and Enterococcus faecalis in the paraffin-embedded tissues of Iranian colorectal cancer patients.
Khodaverdi N; Zeighami H; Jalilvand A; Haghi F; Hesami N
BMC Cancer; 2021 Dec; 21(1):1353. PubMed ID: 34937552
[TBL] [Abstract][Full Text] [Related]
10. Replication Study:
Repass J;
Elife; 2018 Mar; 7():. PubMed ID: 29533182
[TBL] [Abstract][Full Text] [Related]
11. Relationship between
Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
[TBL] [Abstract][Full Text] [Related]
12. Alteration of microRNA-4474/4717 expression and CREB-binding protein in human colorectal cancer tissues infected with Fusobacterium nucleatum.
Feng YY; Zeng DZ; Tong YN; Lu XX; Dun GD; Tang B; Zhang ZJ; Ye XL; Li Q; Xie JP; Mao XH
PLoS One; 2019; 14(4):e0215088. PubMed ID: 30951563
[TBL] [Abstract][Full Text] [Related]
13. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
14. Screening for enterotoxigenic Bacteroides fragilis in stool samples.
Keenan JI; Aitchison A; Purcell RV; Greenlees R; Pearson JF; Frizelle FA
Anaerobe; 2016 Aug; 40():50-3. PubMed ID: 27166180
[TBL] [Abstract][Full Text] [Related]
15. Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.
Chen WD; Zhang X; Zhang YP; Yue CB; Wang YL; Pan HW; Zhang YL; Liu H; Zhang Y
Curr Med Sci; 2022 Jun; 42(3):538-547. PubMed ID: 35678912
[TBL] [Abstract][Full Text] [Related]
16. The presence of bacteria varies between colorectal adenocarcinomas, precursor lesions and non-malignant tissue.
Bundgaard-Nielsen C; Baandrup UT; Nielsen LP; Sørensen S
BMC Cancer; 2019 Apr; 19(1):399. PubMed ID: 31035942
[TBL] [Abstract][Full Text] [Related]
17. Enterotoxigenic
Zamani S; Taslimi R; Sarabi A; Jasemi S; Sechi LA; Feizabadi MM
Front Cell Infect Microbiol; 2019; 9():449. PubMed ID: 32010637
[TBL] [Abstract][Full Text] [Related]
18. Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study.
Shariati A; Razavi S; Ghaznavi-Rad E; Jahanbin B; Akbari A; Norzaee S; Darban-Sarokhalil D
Infect Agent Cancer; 2021 Jun; 16(1):41. PubMed ID: 34108031
[TBL] [Abstract][Full Text] [Related]
19. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome.
Flanagan L; Schmid J; Ebert M; Soucek P; Kunicka T; Liska V; Bruha J; Neary P; Dezeeuw N; Tommasino M; Jenab M; Prehn JH; Hughes DJ
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1381-90. PubMed ID: 24599709
[TBL] [Abstract][Full Text] [Related]
20. The association between fecal enterotoxigenic B. fragilis with colorectal cancer.
Haghi F; Goli E; Mirzaei B; Zeighami H
BMC Cancer; 2019 Sep; 19(1):879. PubMed ID: 31488085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
